Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
| ▸ | CCNC | P24863 | 1/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.40 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | PLAT | P00750 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | LOX | P28300 | 1/20 | 0.39 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4027001 | 0.84 | IDO1 (0.55) | IDO1CCNCCDK8S1PR1PARP10 | |
| SCHEMBL3500189 | 0.83 | MAP4K4 (0.49) | IDO1CCNCCDK8S1PR1MAPKAPK2 | |
| SCHEMBL13453334 | 0.82 | MAPK14 (0.44) | IDO1S1PR1PARP10PARP11MAPK14 | |
| SCHEMBL25070215 | 0.81 | ADORA2A (0.54) | IDO1CCNCCDK8PLAUTDP1 | |
| SCHEMBL4672168 | 0.80 | LMNA (0.52) | IDO1DYRK1ACCNCCDK8S1PR1 | |
| SCHEMBL6506836 | 0.80 | MAPK14 (0.58) | IDO1MAPK14 | |
| SCHEMBL31380443 | 0.80 | ROCK2 (0.45) | IDO1CCNCCDK8MAPK14RECQL | |
| SCHEMBL4903193 | 0.80 | ROCK2 (0.45) | IDO1CCNCCDK8MAPK14RECQL | |
| SCHEMBL28163101 | 0.79 | CCNC (0.46) | IDO1DYRK1ACCNCCDK8S1PR1 | |
| SCHEMBL12050763 | 0.79 | ESR2 (0.47) | IDO1CCNCCDK8MAPKAPK2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708063-A | Phenoxy coordinated fluorine-containing N/C/N/O tetradentate metal platinum (II) complex and application thereof | 浙江工业大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-111362984-A | Compounds, devices, and formulations related to iridium complexes with aza-benzo fused ligands | 环球展览公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-111303212-A | Compounds, devices, and formulations related to iridium complexes with aza-benzo fused ligands | 环球展览公司 | 2020-06-19 | — | — | CN | disclosed |
| EP-3000816-B1 | A FIRST DEVICE COMPRISING IRIDIUM COMPLEXES WITH AZA-BENZO FUSED LIGANDS | UNIVERSAL DISPLAY CORP (US) | 2017-12-20 | — | — | EP | disclosed |
| EP-3000816-B1 | A FIRST DEVICE COMPRISING IRIDIUM COMPLEXES WITH AZA-BENZO FUSED LIGANDS | UNIVERSAL DISPLAY CORP (US) | 2017-12-20 | — | — | EP | disclosed |
| EP-3000816-A1 | A FIRST DEVICE COMPRISING IRIDIUM COMPLEXES WITH AZA-BENZO FUSED LIGANDS | Universal Display Corporation (US) | 2016-03-30 | — | — | EP | disclosed |
| EP-3000816-A1 | A FIRST DEVICE COMPRISING IRIDIUM COMPLEXES WITH AZA-BENZO FUSED LIGANDS | Universal Display Corporation (US) | 2016-03-30 | — | — | EP | disclosed |
| EP-2730583-B1 | Iridium complexes with aza-benzo fused ligands | UNIVERSAL DISPLAY CORP (US) | 2016-01-13 | — | — | EP | disclosed |
| EP-2730583-B1 | Iridium complexes with aza-benzo fused ligands | UNIVERSAL DISPLAY CORP (US) | 2016-01-13 | — | — | EP | disclosed |
| US-8946697-B1 | Iridium complexes with aza-benzo fused ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2015-02-03 | — | — | US | disclosed |
| US-8946697-B1 | Iridium complexes with aza-benzo fused ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2015-02-03 | — | — | US | disclosed |
| US-8946697-B1 | Iridium complexes with aza-benzo fused ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2015-02-03 | — | — | US | disclosed |
| CN-103804426-A | Compounds, devices, and formulations related to iridium complexes with aza-benzo fused ligands | UNIVERSAL DISPLAY CORP | 2014-05-21 | — | — | CN | disclosed |
| EP-2730583-A1 | Iridium complexes with aza-benzo fused ligands | Universal Display Corporation (US) | 2014-05-14 | — | — | EP | disclosed |
| EP-2730583-A1 | Iridium complexes with aza-benzo fused ligands | Universal Display Corporation (US) | 2014-05-14 | — | — | EP | disclosed |
| US-20130065880-A1 | COMPOUNDS AS TYROSINE KINASE MODULATORS | ALLERGAN, INC. (US) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065880-A1 | COMPOUNDS AS TYROSINE KINASE MODULATORS | ABL1, ERBB2, LCK | IDO1 1594/4885FDPS 1518/4885DYRK1A 278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.